[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 93 pages | ID: CDCAA41A2ABDEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Neglected Tropical Disease (NTD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neglected Tropical Disease (NTD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • F. Hoffmann-La Roche
  • Bayer
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Eisai
  • Sanofi
  • Astellas Pharma
  • Takeda Pharmaceutical Company
  • Gilead Sciences
Market segment by Type, the product can be split into
  • Drugs
  • Vaccines
Market segment by Application, split into
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic and Research Organizations
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Neglected Tropical Disease (NTD) Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Neglected Tropical Disease (NTD) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Neglected Tropical Disease (NTD) Treatment are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neglected Tropical Disease (NTD) Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drugs
  1.4.3 Vaccines
1.5 Market by Application
  1.5.1 Global Neglected Tropical Disease (NTD) Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Diagnostic Centers
  1.5.4 Academic and Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Neglected Tropical Disease (NTD) Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Neglected Tropical Disease (NTD) Treatment Industry
    1.6.1.1 Neglected Tropical Disease (NTD) Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Neglected Tropical Disease (NTD) Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Neglected Tropical Disease (NTD) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Neglected Tropical Disease (NTD) Treatment Market Perspective (2015-2026)
2.2 Neglected Tropical Disease (NTD) Treatment Growth Trends by Regions
  2.2.1 Neglected Tropical Disease (NTD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Neglected Tropical Disease (NTD) Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Neglected Tropical Disease (NTD) Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Neglected Tropical Disease (NTD) Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Market Size
  3.1.1 Global Top Neglected Tropical Disease (NTD) Treatment Players by Revenue (2015-2020)
  3.1.2 Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Neglected Tropical Disease (NTD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio
  3.2.1 Global Neglected Tropical Disease (NTD) Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Neglected Tropical Disease (NTD) Treatment Revenue in 2019
3.3 Neglected Tropical Disease (NTD) Treatment Key Players Head office and Area Served
3.4 Key Players Neglected Tropical Disease (NTD) Treatment Product Solution and Service
3.5 Date of Enter into Neglected Tropical Disease (NTD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Neglected Tropical Disease (NTD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Type (2021-2026)

5 NEGLECTED TROPICAL DISEASE (NTD) TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)
5.2 Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
6.2 Neglected Tropical Disease (NTD) Treatment Key Players in North America (2019-2020)
6.3 North America Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
6.4 North America Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
7.2 Neglected Tropical Disease (NTD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
7.4 Europe Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
8.2 Neglected Tropical Disease (NTD) Treatment Key Players in China (2019-2020)
8.3 China Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
8.4 China Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
9.2 Neglected Tropical Disease (NTD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
9.4 Japan Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
10.2 Neglected Tropical Disease (NTD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
11.2 Neglected Tropical Disease (NTD) Treatment Key Players in India (2019-2020)
11.3 India Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
11.4 India Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Neglected Tropical Disease (NTD) Treatment Market Size (2015-2020)
12.2 Neglected Tropical Disease (NTD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 F. Hoffmann-La Roche
  13.1.1 F. Hoffmann-La Roche Company Details
  13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.1.3 F. Hoffmann-La Roche Neglected Tropical Disease (NTD) Treatment Introduction
  13.1.4 F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020))
  13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Bayer
  13.2.1 Bayer Company Details
  13.2.2 Bayer Business Overview and Its Total Revenue
  13.2.3 Bayer Neglected Tropical Disease (NTD) Treatment Introduction
  13.2.4 Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.2.5 Bayer Recent Development
13.3 GlaxoSmithKline
  13.3.1 GlaxoSmithKline Company Details
  13.3.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.3.3 GlaxoSmithKline Neglected Tropical Disease (NTD) Treatment Introduction
  13.3.4 GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.3.5 GlaxoSmithKline Recent Development
13.4 Novartis
  13.4.1 Novartis Company Details
  13.4.2 Novartis Business Overview and Its Total Revenue
  13.4.3 Novartis Neglected Tropical Disease (NTD) Treatment Introduction
  13.4.4 Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.4.5 Novartis Recent Development
13.5 Pfizer
  13.5.1 Pfizer Company Details
  13.5.2 Pfizer Business Overview and Its Total Revenue
  13.5.3 Pfizer Neglected Tropical Disease (NTD) Treatment Introduction
  13.5.4 Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.5.5 Pfizer Recent Development
13.6 Eisai
  13.6.1 Eisai Company Details
  13.6.2 Eisai Business Overview and Its Total Revenue
  13.6.3 Eisai Neglected Tropical Disease (NTD) Treatment Introduction
  13.6.4 Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.6.5 Eisai Recent Development
13.7 Sanofi
  13.7.1 Sanofi Company Details
  13.7.2 Sanofi Business Overview and Its Total Revenue
  13.7.3 Sanofi Neglected Tropical Disease (NTD) Treatment Introduction
  13.7.4 Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.7.5 Sanofi Recent Development
13.8 Astellas Pharma
  13.8.1 Astellas Pharma Company Details
  13.8.2 Astellas Pharma Business Overview and Its Total Revenue
  13.8.3 Astellas Pharma Neglected Tropical Disease (NTD) Treatment Introduction
  13.8.4 Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.8.5 Astellas Pharma Recent Development
13.9 Takeda Pharmaceutical Company
  13.9.1 Takeda Pharmaceutical Company Company Details
  13.9.2 Takeda Pharmaceutical Company Business Overview and Its Total Revenue
  13.9.3 Takeda Pharmaceutical Company Neglected Tropical Disease (NTD) Treatment Introduction
  13.9.4 Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.9.5 Takeda Pharmaceutical Company Recent Development
13.10 Gilead Sciences
  13.10.1 Gilead Sciences Company Details
  13.10.2 Gilead Sciences Business Overview and Its Total Revenue
  13.10.3 Gilead Sciences Neglected Tropical Disease (NTD) Treatment Introduction
  13.10.4 Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
  13.10.5 Gilead Sciences Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Neglected Tropical Disease (NTD) Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Neglected Tropical Disease (NTD) Treatment Revenue
Table 3. Ranking of Global Top Neglected Tropical Disease (NTD) Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs
Table 6. Key Players of Vaccines
Table 7. COVID-19 Impact Global Market: (Four Neglected Tropical Disease (NTD) Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Neglected Tropical Disease (NTD) Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Neglected Tropical Disease (NTD) Treatment Players to Combat Covid-19 Impact
Table 12. Global Neglected Tropical Disease (NTD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Neglected Tropical Disease (NTD) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Neglected Tropical Disease (NTD) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Neglected Tropical Disease (NTD) Treatment Market Share by Regions (2015-2020)
Table 16. Global Neglected Tropical Disease (NTD) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Neglected Tropical Disease (NTD) Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Neglected Tropical Disease (NTD) Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Neglected Tropical Disease (NTD) Treatment Players
Table 23. Global Neglected Tropical Disease (NTD) Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players (2015-2020)
Table 25. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2019)
Table 26. Global Neglected Tropical Disease (NTD) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Neglected Tropical Disease (NTD) Treatment Product Solution and Service
Table 29. Date of Enter into Neglected Tropical Disease (NTD) Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Neglected Tropical Disease (NTD) Treatment Market Size Share by Type (2015-2020)
Table 33. Global Neglected Tropical Disease (NTD) Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Neglected Tropical Disease (NTD) Treatment Market Size Share by Application (2015-2020)
Table 35. Global Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Neglected Tropical Disease (NTD) Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 39. North America Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 41. North America Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 45. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 47. Europe Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 51. China Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 53. China Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 57. Japan Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 59. Japan Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 63. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 69. India Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 71. India Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Neglected Tropical Disease (NTD) Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Neglected Tropical Disease (NTD) Treatment Market Share (2019-2020)
Table 75. Central & South America Neglected Tropical Disease (NTD) Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Neglected Tropical Disease (NTD) Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Neglected Tropical Disease (NTD) Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Neglected Tropical Disease (NTD) Treatment Market Share by Application (2015-2020)
Table 79. F. Hoffmann-La Roche Company Details
Table 80. F. Hoffmann-La Roche Business Overview
Table 81. F. Hoffmann-La Roche Product
Table 82. F. Hoffmann-La Roche Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 83. F. Hoffmann-La Roche Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Pfizer Company Details
Table 100. Pfizer Business Overview
Table 101. Pfizer Product
Table 102. Pfizer Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 103. Pfizer Recent Development
Table 104. Eisai Company Details
Table 105. Eisai Business Overview
Table 106. Eisai Product
Table 107. Eisai Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 108. Eisai Recent Development
Table 109. Sanofi Company Details
Table 110. Sanofi Business Overview
Table 111. Sanofi Product
Table 112. Sanofi Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 113. Sanofi Recent Development
Table 114. Astellas Pharma Business Overview
Table 115. Astellas Pharma Product
Table 116. Astellas Pharma Company Details
Table 117. Astellas Pharma Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 118. Astellas Pharma Recent Development
Table 119. Takeda Pharmaceutical Company Company Details
Table 120. Takeda Pharmaceutical Company Business Overview
Table 121. Takeda Pharmaceutical Company Product
Table 122. Takeda Pharmaceutical Company Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 123. Takeda Pharmaceutical Company Recent Development
Table 124. Gilead Sciences Company Details
Table 125. Gilead Sciences Business Overview
Table 126. Gilead Sciences Product
Table 127. Gilead Sciences Revenue in Neglected Tropical Disease (NTD) Treatment Business (2015-2020) (Million US$)
Table 128. Gilead Sciences Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Neglected Tropical Disease (NTD) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Global Neglected Tropical Disease (NTD) Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. Academic and Research Organizations Case Studies
Figure 8. Neglected Tropical Disease (NTD) Treatment Report Years Considered
Figure 9. Global Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neglected Tropical Disease (NTD) Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Neglected Tropical Disease (NTD) Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neglected Tropical Disease (NTD) Treatment Market Share by Players in 2019
Figure 14. Global Top Neglected Tropical Disease (NTD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neglected Tropical Disease (NTD) Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neglected Tropical Disease (NTD) Treatment Revenue in 2019
Figure 16. North America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Neglected Tropical Disease (NTD) Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. F. Hoffmann-La Roche Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 25. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bayer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 27. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 29. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Novartis Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 33. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eisai Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sanofi Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 37. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Astellas Pharma Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 39. Takeda Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Takeda Pharmaceutical Company Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 41. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Gilead Sciences Revenue Growth Rate in Neglected Tropical Disease (NTD) Treatment Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed


More Publications